Clinical trial
An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse (ASPIRE)
NCT05306925 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse (ASPIRE)
- Lead sponsor
- University of Liverpool
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 14, 2022
- Completion date
- December 31, 2026
- Enrollment
- 48 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
immune system and related disorders, nutritional deficiency, preterm, surgery